CONICET | Buscador de Institutos y Recursos Humanos

In this review we describe how highly addictive psychostimulants such as cocaine and methamphetamineactions might underlie hypoexcitabilty in frontal cortical areas observed in clinical and preclinical modelsof psychostimulant abuse. We discuss new mechanisms that describe how increments on synapticdopamine release are linked to reduce calcium influx in both pre and postsynaptic compartments onmedial PFC networks, therefore modulating synaptic integration and information. Sustained DA neuromodulationby addictive psychostimulants can ?lock? frontal cortical networks in deficient states. On theother hand, other psychostimulants such as modafinil and methylphenidate are considered pharmacologicalneuroenhancement agents that are popular among healthy people seeking neuroenhancement.More clinical and preclinical research is needed to further clarify mechanisms of actions and physiologicaleffects of cognitive enhancers which show an opposite pattern compared to chronic effect of addictivepsychostimulants: they appear to increase cortical excitability. In conclusion, studies summarizedhere suggest that there is frontal cortex hypoactivity and deficient inhibitory control in drug-addictedindividuals. Thus, additional research on physiological effects of cognitive enhancers like modafinil andmethylphenidate seems necessary in order to expand current knowledge on mechanisms behind theirtherapeutic role in the treatment of addiction and other neuropsychiatric disorders.